Inhibidores de la PSCK9. Su futuro en el tratamiento de las dislipidemias

Rivas, Juan Carlos

Inhibidores de la PSCK9. Su futuro en el tratamiento de las dislipidemias / Inhibitors of PCSK9. Your future in the treatment of dyslipidemias

Rivas, Juan Carlos.

Affiliation

Rivas, Juan Carlos; Instituto Cardiovascular de Rosario. Director de la Sección Lípidos. Rosario. AR

Rev. med. Rosario ; 82(1): 14-16, ene.-abr. 2016. tab

Article in Es | LILACS | ID: biblio-836199

Responsible library: AR16.1

Subject(s)

Humans; Male; Female; Dyslipidemias/therapy; Dyslipidemias/therapy; Proprotein Convertases; Subtilisin; Antibodies, Monoclonal; Cardiovascular Diseases; Cholesterol, LDL; Hyperlipoproteinemia Type II/therapy; Hyperlipoproteinemia Type II/therapy; Pharmaceutical Preparations

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: LILACS Main subject: Subtilisin / Proprotein Convertases / Dyslipidemias Limits: Female / Humans / Male Language: Es Journal: Rev. med. Rosario Journal subject: MEDICINA Year: 2016 Type: Article

Fulltext

Add to My VHL

XML

Search on Google